OPEX Ratio Alignment & Portfolio Valuation Overview slide image

OPEX Ratio Alignment & Portfolio Valuation Overview

INCOME STATEMENT | 2Q22 & 1H22 Income statement GEL '000, unless otherwise noted 2Q22 2Q21 Change 1H22 1H21 Change Dividend income 32,226 9,691 NMF 34,421 14,430 NMF Interest income 9,364 6,120 53.0% 18,150 10,617 71.0% Realised/unrealised (loss)/ gain on liquid funds (1,197) 1,687 NMF (11,435) 1,516 NMF Interest expense (17,826) (20,302) -12.2% (37,679) (37,520) 0.4% Gross operating income/(loss) 22,567 (2,804) NMF 3,457 (10,957) NMF Operating expenses GCAP net operating income/(loss) (10,395) (9,225) 12.7% (19,700) (18,096) 8.9% 12,172 (12,029) NMF (16,243) (29,053) -44.1% Fair value changes of portfolio companies Listed and observable portfolio companies (4,152) 70,288 NMF (211,859) 43,836 NMF Bank of Georgia Group PLC Water Utility (17,760) 70,288 NMF (225,467) 43,836 NMF 13,608 NMF 13,608 NMF Private portfolio companies Large Portfolio Companies Of which, Retail (pharmacy) Of which, Hospitals (42,520) 251,933 NMF (287,828) 282,183 NMF (21,396) 197,356 NMF (163,928) 201,855 NMF 13,948 44,816 -68.9% (39,358) 27,657 NMF (46,250) 64,276 NMF (95,769) 90,889 NMF Of which, Water Utility 91,100 NMF 76,097 NMF Of which, Insurance (P&C and Medical) 10,906 (2,836) NMF (28,801) 7,212 NMF Investment Stage Portfolio Companies (3,536) 48,976 NMF (19,219) 54,115 NMF Of which, Renewable energy 8,050 13,072 -38.4% (2,002) 7,632 NMF Of which, Education 16,385 19,443 -15.7% 20,741 23,207 -10.6% Of which, Clinics and Diagnostics (27,971) 16,461 NMF (37,958) 23,276 NMF Other businesses (17,588) 5,601 NMF (104,681) 26,213 NMF Total investment return (46,672) 322,221 NMF (499,687) 326,019 NMF (Loss)/income before foreign exchange movements (34,500) 310,192 NMF (515,930) 296,966 NMF and non-recurring expenses Net foreign currency loss 18,172 Non-recurring expenses Net (loss)/income (adjusted IFRS) (104) (16,432) 57,988 (41) 368,139 -68.7% NMF NMF 14,448 (196) (501,678) 26,547 -45.6% (218) -10.1% 323,295 NMF GEORGIA CAPITAL 97
View entire presentation